Paid Clinical Trials Concord

Discover 308 paid clinical trials in Concord, New Hampshire. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 308

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative ColitisA Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Recruiting

PHASE2

Sponsor:

Pfizer

Location:

Lebanon NH, Boston MA, Rochester NY, Cleveland OHshow 14 more

Code:

NCT05287126

Conditions

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Study of Trilaciclib and LurbinectidinStudy of Trilaciclib and Lurbinectidin

Recruiting

PHASE2

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Location:

Lebanon NH, Chapel Hill NC

Code:

NCT05578326

Conditions

Lung Cancer

Small-cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Trilaciclib

Lurbinectedin

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLCTo Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Recruiting

PHASE3

Sponsor:

Shanghai Henlius Biotech

Location:

Lebanon NH, Burlington MA, Boston MA, Providence RIshow 85 more

Code:

NCT05468489

Conditions

Extensive Stage Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Serplulimab + chemotherapy (carboplatin-etoposide)

Atezolizumab + chemotherapy (carboplatin-etoposide)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Concord NH, Manchester NH, Newburyport MA, Lebanon NHshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid TumorsA Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Recruiting

PHASE1

Sponsor:

Conjupro Biotherapeutics, Inc.

Location:

Lebanon NH, Philadelphia PA, Toronto, Hamiltonshow 9 more

Code:

NCT05948865

Conditions

Cancer

Cancer, Lung

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CPO301

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening IschemiaPROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

Recruiting

Sponsor:

LimFlow, Inc.

Location:

Lebanon NH, Boston MA, Worcester MA, New Haven CTshow 21 more

Code:

NCT05313165

Conditions

Critical Limb Ischemia

Chronic Limb-Threatening Ischemia

Peripheral Arterial Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

LimFlow Stent Graft System

OCT in Open Fracture and Infected FractureOCT in Open Fracture and Infected Fracture

Recruiting

Sponsor:

Dartmouth-Hitchcock Medical Center

Location:

Lebanon NH

Code:

NCT05785182

Conditions

Trauma Injury

Trauma

Open Fracture

Fracture Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Open Fracture

Infected Fracture

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Portsmouth NH, Brighton MA, Bronx NY, Hackensack NJshow 47 more

Code:

NCT06516965

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo

SPYRAL AFFIRM Global Study of RDN with the Symplicity Spyral RDN System in Subjects with Uncontrolled HTNSPYRAL AFFIRM Global Study of RDN with the Symplicity Spyral RDN System in Subjects with Uncontrolled HTN

Recruiting

Sponsor:

Medtronic Vascular

Location:

Lebanon NH, Boston MA, Providence RI, Hartford CTshow 66 more

Code:

NCT05198674

Conditions

Hypertension

Vascular Diseases

Cardiovascular Diseases

Chronic Kidney Diseases

Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Renal Denervation (Symplicity Spyral™)

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Recruiting

PHASE3

Sponsor:

GT Medical Technologies, Inc.

Location:

Lebanon NH, Providence RI, Albany NY, Westchester NYshow 27 more

Code:

NCT04365374

Conditions

Brain Metastases

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)

Stereotactic Radiation Therapy